Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 2 boards, counting each seat separately. Longest: Tarsus Pharmaceuticals Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Achieve Life Sciences Inc. July 2, 202699.5%
-
Tarsus Pharmaceuticals Inc. June 25, 202676.9%
-
Tarsus Pharmaceuticals Inc. June 22, 202394.1%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 12, 2026 | Tarsus Pharmaceuticals Inc. | Option exercise | +2,954 | — | — |
| Jun 13, 2025 | Tarsus Pharmaceuticals Inc. | Option exercise | +3,350 | — | — |
| Mar 7, 2025 | Tarsus Pharmaceuticals Inc. | Option exercise | +7,000 | $12.89 | $90,230 |
| Jun 24, 2024 | Tarsus Pharmaceuticals Inc. | Option exercise | +3,350 | — | — |
| Dec 15, 2023 | Tarsus Pharmaceuticals Inc. | Open-market purchase | +1,000 | $18.96 | $18,960 |
| Jun 16, 2023 | Tarsus Pharmaceuticals Inc. | Option exercise | +2,000 | — | — |
Questions about Andrew D. Goldberg
What boards is Andrew D. Goldberg on?
Andrew D. Goldberg sits on the boards of Achieve Life Sciences Inc. and Tarsus Pharmaceuticals Inc.
What company is Andrew D. Goldberg the CEO of?
Andrew D. Goldberg has been CEO and President of Achieve Life Sciences Inc. since April 2026.
How long has Andrew D. Goldberg served on boards?
Our records show at least 4 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.